Division of Clinical Microbiology, Department of Pathology and Laboratory Medicine, Henry Ford Health, Detroit, Michigan, USA.
J Clin Microbiol. 2023 Jul 20;61(7):e0023121. doi: 10.1128/jcm.00231-21. Epub 2023 May 24.
Blood cultures have been the staple of clinical microbiology laboratories for well over half a century, but gaps remain in our ability to identify the causative agent in patients presenting with signs and symptoms of sepsis. Molecular technologies have revolutionized the clinical microbiology laboratory in many areas but have yet to present a viable alternative to blood cultures. There has been a recent surge of interest in utilizing novel approaches to address this challenge. In this minireview, I discuss whether molecular tools will finally give us the answers we need and the practical challenges of incorporating them into the diagnostic algorithm.
血液培养在临床微生物学实验室已经有半个多世纪的历史了,但在识别出现败血症症状和体征的患者的病原体方面,我们的能力仍存在差距。分子技术已经彻底改变了临床微生物学实验室的许多领域,但尚未提供一种可行的血液培养替代方法。最近,人们对利用新方法来解决这一挑战产生了浓厚的兴趣。在这篇简评中,我将讨论分子工具是否最终会为我们提供所需的答案,以及将它们纳入诊断算法的实际挑战。